These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12597159)

  • 1. [Rationales for the integration of molecular and conventional therapies].
    Tortora G; Ciardiello F
    Tumori; 2002; 88(6):A9-13. PubMed ID: 12597159
    [No Abstract]   [Full Text] [Related]  

  • 2. Introducing the BECT (biologically enhanced cytotoxic treatment) concept in cancer treatment.
    Bernier J; Bourhis J
    Ann Oncol; 2005 Nov; 16(11):1722. PubMed ID: 16087695
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiovascular complications of oncological therapy].
    Grabowska B; Stepińska J
    Kardiol Pol; 2004 Sep; 61(9):296-9. PubMed ID: 15531946
    [No Abstract]   [Full Text] [Related]  

  • 4. Antioxidants and chemotherapy.
    Galland L
    Altern Ther Health Med; 2007; 13(5):13. PubMed ID: 17900036
    [No Abstract]   [Full Text] [Related]  

  • 5. The legacy of cancer therapy in children.
    Fox E; Citrin D; Balis FM
    J Natl Cancer Inst; 2009 Aug; 101(16):1105-7. PubMed ID: 19648512
    [No Abstract]   [Full Text] [Related]  

  • 6. Concomitant chemotherapy and radiotherapy: theoretical basis and clinical experience.
    Colin PH
    Anticancer Res; 1994; 14(6A):2357-61. PubMed ID: 7825972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An update: stem cell and cancer stem cells].
    Liu YQ
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):511-2. PubMed ID: 20021959
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardioprotective treatment during adjuvant cancer therapy].
    Gulati G; Heck SL; Ree AH; Gravdehaug B; Røsjø H; Steine K; Bratland Å; Hoffmann P; Geisler J; Omland T
    Tidsskr Nor Laegeforen; 2013 Sep; 133(17):1832-6. PubMed ID: 24042297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune infiltrate in cancer.
    Stoll G; Zitvogel L; Kroemer G
    Aging (Albany NY); 2015 Jun; 7(6):358-9. PubMed ID: 26143478
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term consequences of anticancer therapy in children].
    Kuleva SA; Kolygin BA
    Vopr Onkol; 2012; 58(4):454-63. PubMed ID: 23607198
    [No Abstract]   [Full Text] [Related]  

  • 11. Oncogastroenterology.
    Grover S; Lim RM; Blumberg RS; Syngal S
    J Clin Oncol; 2016 Apr; 34(10):1154-5. PubMed ID: 26834060
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemoradiotherapy. Therapeutic indications: the doctor's point of view].
    Natale D; Orlando D
    Suppl Tumori; 2004; 3(4):S123-4. PubMed ID: 15206236
    [No Abstract]   [Full Text] [Related]  

  • 13. Strategies for modern biomarker and drug development in oncology.
    Smith AD; Roda D; Yap TA
    J Hematol Oncol; 2014 Oct; 7():70. PubMed ID: 25277503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual tailored chemotherapy.
    Beretta GD; Labianca R
    Suppl Tumori; 2002; 1(6):S25-7. PubMed ID: 12658899
    [No Abstract]   [Full Text] [Related]  

  • 15. PD-L1 Testing in Cancer: Challenges in Companion Diagnostic Development.
    Hansen AR; Siu LL
    JAMA Oncol; 2016 Jan; 2(1):15-6. PubMed ID: 26562503
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of access to targeted cancer therapy.
    Burki TK
    Lancet Oncol; 2015 Oct; 16(13):e482. PubMed ID: 26321211
    [No Abstract]   [Full Text] [Related]  

  • 17. MKK3 as oncotarget.
    Bossi G
    Aging (Albany NY); 2016 Jan; 8(1):1-2. PubMed ID: 26805700
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of chemoradiation on tumor-host interactions: the immunologic side.
    Formenti SC; Demaria S
    J Clin Oncol; 2008 Mar; 26(9):1562-3; author reply 1563. PubMed ID: 18349411
    [No Abstract]   [Full Text] [Related]  

  • 19. Validation of analytic methods for biomarkers used in drug development.
    Chau CH; Rixe O; McLeod H; Figg WD
    Clin Cancer Res; 2008 Oct; 14(19):5967-76. PubMed ID: 18829475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evolution of the parameters indicating response to drug therapy: from regression to complete control of the disease and the symptoms].
    Cascinu S; Camisa R; D'Angelo A; Salvagni S
    Tumori; 2002; 88(6):A7-9. PubMed ID: 12597158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.